Note: The full article and accompanying features are only available whilst being signed in.
Summary
Pharmaceutical Companies can no longer ignore the hidden value available by increasing patient adherence. Companies who implement strategies to increase adherence and persistence with their products can better face the numerous challenges in today’s market and increase their share of profits.
This report examines adherence among today’s Pharmaceutical consumers, analyzing the statistics, clinical costs, and reasons for non-adherence. Current approaches to improving adherence are explored, along with key elements of successful Pharma Company adherence initiatives. We also investigate the elusive ROI and discuss the complex issues surrounding adherence initiatives and return on investment. Finally, a case study on utilizing analytics to improve adherence programs demonstrates the best methods to leverage existing clients, making the most of what specific companies (and the greater Pharma Industry) already have.
To purchase this report, please visit:
> Releasing the Hidden Value from Patient Compliance/Adherence Programs
Want more?
The content of this page been summarized. To view the full content, please register or sign in to the Eularis web site.
Register with Eularis
or
Sign in